Feb 3, 2023 05:55AM
Feb 3, 2023 01:00AM
Feb 3, 2023 01:00AM
Aug 5, 2022 01:00AM
Aug 5, 2022 01:00AM
Aug 1, 2022 05:52AM
Aug 1, 2022 01:01AM Celyad Oncology Announces FDA Lifts Clinical Hold of CYAD-101-002 Phase 1b Trial
Aug 1, 2022 01:01AM
May 5, 2022 06:12PM
May 5, 2022 05:31PM
May 5, 2022 04:05PM
May 5, 2022 04:01PM
Mar 24, 2022 04:05PM
Mar 24, 2022 04:02PM Celyad Oncology Reports Full Year 2021 Financial Results and Recent Business Highlights
Mar 2, 2022 05:49AM
Mar 2, 2022 02:30AM
Mar 2, 2022 02:30AM
Dec 7, 2020 01:00AM
Dec 7, 2020 01:00AM
Dec 4, 2020 05:56AM
Dec 4, 2020 01:00AM Celyad Oncology Announces Dosing of First Patient in Phase 1 IMMUNICY-1 Trial of CYAD-211 for Multiple Myeloma
Dec 4, 2020 01:00AM
Nov 10, 2020 04:01PM
Nov 10, 2020 04:00PM
Nov 4, 2020 04:01PM
Nov 4, 2020 04:00PM
Aug 6, 2020 04:01PM
Aug 6, 2020 04:00PM Celyad Oncology Reports Half Year 2020 Financial Results and Second Quarter Business Highlights
Jul 14, 2020 05:51AM
Jul 14, 2020 01:00AM
Jul 14, 2020 01:00AM
Sep 10, 2019 04:00AM
Aug 22, 2019 04:00PM
Jul 8, 2019 03:33AM
Jul 1, 2019 04:04PM Celyad SA (CYAD) Announces Strategic Updates to Autologous r/r AML and MDS Program
Jul 1, 2019 04:01PM
Nov 21, 2018 01:00AM
Nov 21, 2018 01:00AM
Nov 9, 2018 12:48PM
Nov 9, 2018 12:45PM
Nov 9, 2018 12:45PM
Aug 23, 2018 01:17AM Celyad Reports First Half 2018 Financial Results and Operational Progress
Aug 23, 2018 01:00AM
Jul 24, 2018 05:51AM
Jul 24, 2018 01:00AM
Jul 24, 2018 01:00AM
May 25, 2018 09:18AM
Aug 29, 2017 01:00AM
Aug 29, 2017 01:00AM Celyad Reports First Half 2017 Financial Results and Operational Progress
May 19, 2017 01:00AM

322,243 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All